288
We describe a continuous ambulatory peritoneal dialysis (CAPD) patient that developed vancomycin-induced agranulocytosis during treatment for methicillin-resistant Staphylococcus aureus (MRSA)-associated external cuff infection and pneumonia.
 a continuous ambulatory peritoneal dialysis (CAPD) patient: Subject; continuous ambulatory peritoneal dialysis (CAPD): Subject.Disorder; agranulocytosis: Effect; vancomycin: Treatment; methicillin-resistant Staphylococcus aureus (MRSA)-associated external cuff infection and pneumonia: Treatment.Disorder; vancomycin: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a continuous ambulatory peritoneal dialysis (CAPD) patient: Subject; continuous ambulatory peritoneal dialysis (CAPD): Subject.Disorder; agranulocytosis: Effect; vancomycin: Treatment; methicillin-resistant Staphylococcus aureus (MRSA)-associated external cuff infection and pneumonia: Treatment.Disorder; vancomycin: Treatment.Drug